围绝经期与绝经期的健康管理：最大化健康与活力
摘要
Mary Claire Haver博士是一位经过委员会认证的妇产科医师，她对围绝经期和绝经期的生物学机制、症状及治疗方案进行了全面解析。她阐释了雌激素水平下降和波动如何对身体成分、心血管健康、心理健康及认知功能产生广泛影响。讨论尤其着重于纠正关于激素替代疗法（HRT）的危险误解——这些误解源于2002年存在严重缺陷的女性健康倡议（WHI）研究。
核心要点
- 围绝经期始于末次月经前7–10年（平均绝经年龄：51–52岁），这意味着症状可能在女性40岁出头至40岁中期便开始出现。
- 激素治疗的时机至关重要：在50–59岁之间开始HRT与心血管疾病风险及全因死亡率降低约50%相关。
- WHI研究存在严重缺陷：该研究纳入的女性平均年龄为63岁（绝经后10–12年），并排除了有潮热症状的女性，使其关于雌激素致癌的结论具有误导性。
- 绝经期内脏脂肪急剧增加：绝经前女性的内脏脂肪平均约占8%；完成绝经过渡后，即使饮食和运动习惯不变，这一比例也会上升至约23%。
- 蛋白质摄入量严重被低估：大多数女性每日摄入50–60g，但为了保持肌肉量、预防虚弱，可能需要每日摄入80–120g（或约1.5–1.7g/kg瘦体重）。
- 膳食纤维摄入量应达到25–32g/天，而大多数西方女性每日仅摄入10–12g。
- 每周3–4次抗阻训练对于在绝经过渡期保持肌肉量、骨密度和代谢健康至关重要。
- 每5名女性中就有1人因绝经症状辞职，凸显了绝经对经济和心理造成的巨大却被严重忽视的影响。
- 加速提前绝经的因素包括吸烟、子宫切除术（提前约4年）、输卵管结扎（提前约1.5年）、子宫内膜异位症、化疗及腹部炎性疾病。
- 仅有10%出现绝经症状的女性被提供任何治疗方案；她们被开具抗抑郁药的可能性是被提供激素治疗的四倍。
详细说明
绝经与围绝经期的定义
- 绝经在医学上被定义为末次月经后满一年——但Haver博士批评这一定义对于放置宫内节育器、已行子宫切除术、多囊卵巢综合征或子宫内膜消融术的女性而言并不适用。
- 更具实际意义的定义：卵巢功能的终止，以雌二醇和孕酮生成几乎完全停止为特征。
- 女性出生时拥有100–200万个卵子；30岁时约剩余10%（约12万个）；40岁时约剩余3%。
- 睾酮在绝经时也会下降，降至生育高峰期水平的50%或更低。
- 围绝经期 = 末次月经前的7–10年，以激素水平混乱、不可预测的波动为特征——被称为**“混乱区间”**。
- 随着卵巢反应减弱，促卵泡素（FSH）大幅升高；雌二醇在最终趋于平稳之前会出现剧烈震荡。
- 目前没有可靠的血液检测方法用于诊断围绝经期——诊断主要依赖临床表现和症状评估。
围绝经期症状
- 月经变化：月经不规律、经量增多或停经（约90%的女性受影响）
- 心理健康：焦虑加重、出现类似注意力缺陷障碍的新发症状、脑雾、执行功能下降、抑郁、抗压能力减弱
- 血管舒缩症状：潮热、盗汗、心悸
- 睡眠障碍：入睡困难或睡眠维持困难
- 肌肉骨骼症状：关节疼痛、髋部疼痛、腰背痛，且无可查明的结构性原因
- 其他症状：疲劳、眩晕、耳鸣、皮肤干燥/瘙痒、皮肤爬行感、肠道变化/腹胀、自信心下降
- 在绝经过渡期，选择性5-羟色胺再摄取抑制剂（SSRI）的处方率翻倍；激素治疗对于绝经相关抑郁的疗效可能优于SSRI
身体成分变化
- 内脏脂肪（包绕内脏器官的脂肪）在绝经过渡期占总脂肪的比例从约8%上升至约23%——即使饮食和运动习惯未发生任何变化。
- 肌少症（肌肉流失）加速，导致基础代谢率降低并加剧胰岛素抵抗。
- 腰臀比是评估内脏脂肪风险的实用指标：
- < 0.7 = 代谢风险较低
- > 1.0 = 内脏脂肪可能偏高
- 测量方法：腰围取最细处（若无明显腰部曲线则取肚脐处），臀围取最宽处，放松状态下于清晨测量
- 身体成分（而非单纯体重）才是有意义的评估指标——即使肌肉流失、脂肪增加，体重秤上的数字也可能没有变化。
营养建议
- 蛋白质：每日至少摄入80–120g；WHI的高端数据显示，按1.5–1.7g/kg瘦体重摄入可降低虚弱风险。应将蛋白质分散在各餐中摄入，不要集中在晚餐。
- 膳食纤维：目标为每日25–32g（大多数女性仅摄入10–12g）。好处包括：滋养肠道微生物群、减缓葡萄糖吸收、促进肠道蠕动。
- 抗炎饮食模式：地中海饮食以及Galveston饮食（一种美式、抗炎、高蛋白饮食，可选择性加入间歇性禁食元素）。
- 摄入多种颜色的食物（植物化学物质）；加入发酵食品以促进肠道健康。
- 尽量减少加工食品和高糖食品的摄入。
运动
- 抗阻训练每周3–4次是首要选择——而非有氧运动——以在此人生阶段保护肌肉、骨骼和代谢健康。
- 渐进式超负荷是关键；建议与私人教练合作，制定安全的训练计划。
- 在此人生阶段，减少或替换过度的有氧运动（如马拉松训练），转而进行抗阻训练，对长期健康更为有益。
肠道微生物群与绝经
- Zoe营养研究（n=1,100）显示，女性在围绝经期经历了可测量的肠道微生物群变化——从典型的女性微生物群特征向男性特征转变。
- 针对绝经期女性的益生菌研究（乳酸杆菌、双歧杆菌）显示，内脏脂肪和血压均有所改善。
- 回顾性研究表明，以饮食为基础的支持方式（酸奶、发酵食品、高纤维食物）与更少的绝经症状相关。
激素替代疗法（HRT）
- 是治疗潮热及许多其他绝经症状的金标准方案。
- 可恢复雌激素信号传导，重新校准下丘脑体温调节中枢，并支持神经递质功能（血清素、多巴胺、去甲肾上腺素）。
WHI研究——问题出在哪里
- 参与者平均年龄：63岁（绝经后10–12年）——远超关键治疗窗口期。
- 排除了有潮热症状的女性以保持盲法——去除了症状最严重的人群。
- 乳腺癌风险的增加是相对风险，而非绝对风险：从每年每1,000名女性中4例增至5例（绝对风险增加仅为千分之一）。
- 仅雌激素组（无子宫的女性）显示乳腺癌风险降低30%。
- 研究结果在同行评审之前便通过新闻发布会公布——引发大规模媒体恐慌。
数据真正说明了什么
- 在50–59岁开始HRT：心血管疾病风险和全因死亡率降低约50%（美国心脏协会，2020年分析）。
- “时机假说”：雌激素在绝经初期开始使用时具有保护作用；在动脉粥样硬化已形成后再开始使用，效果减弱（对卒中风险可能有害）。
- 较长的终生雌激素暴露时间（自然周期＋HRT）与更高的认知评分和更健康的大脑老化相关。
- 女性
English Original 英文原文
Navigating Perimenopause & Menopause for Maximum Health & Vitality
Summary
Dr. Mary Claire Haver, a board-certified OB/GYN, provides a comprehensive breakdown of the biology, symptoms, and treatment options for perimenopause and menopause. She explains how declining and chaotic estrogen levels drive wide-ranging effects on body composition, cardiovascular health, mental health, and cognition. The discussion places particular emphasis on correcting dangerous misconceptions about hormone replacement therapy (HRT) stemming from the flawed 2002 Women’s Health Initiative (WHI) study.
Key Takeaways
- Perimenopause begins 7–10 years before the final menstrual period (average menopause age: 51–52), meaning symptoms can start in a woman’s early-to-mid 40s.
- Hormone therapy timing is critical: Starting HRT between ages 50–59 is associated with a ~50% reduced risk of cardiovascular disease and all-cause mortality.
- The WHI study was deeply flawed: It enrolled women averaging age 63 (10–12 years post-menopause) and excluded women with hot flashes, making its conclusions about estrogen causing cancer misleading.
- Visceral fat surges at menopause: Premenopausal women average ~8% visceral fat; post-transition this rises to ~23% with no changes in diet or exercise.
- Protein intake is critically underemphasized: Most women consume 50–60g/day, but 80–120g/day (or ~1.5–1.7g/kg lean body mass) is likely needed to preserve muscle and prevent frailty.
- Fiber intake should reach 25–32g/day, yet most Western women consume only 10–12g/day.
- Resistance training 3–4 days/week is essential for preserving muscle mass, bone density, and metabolic health through the menopause transition.
- 1 in 5 women quit their jobs due to menopause symptoms, highlighting the massive but underrecognized economic and psychological impact.
- Factors that accelerate early menopause include smoking, hysterectomy (−4 years), tubal ligation (−1.5 years), endometriosis, chemotherapy, and abdominal inflammatory conditions.
- Only 10% of women presenting with menopausal symptoms are offered any therapy; they are four times more likely to be offered an antidepressant.
Detailed Notes
Defining Menopause and Perimenopause
- Menopause is officially defined as one year after the final menstrual period — but Dr. Haver critiques this definition as inadequate for women with IUDs, hysterectomies, PCOS, or ablations.
- A more meaningful definition: the end of ovarian function, characterized by near-total loss of estradiol and progesterone production.
- Women are born with 1–2 million eggs; by age 30, ~10% remain (~120,000); by age 40, ~3%.
- Testosterone also declines at menopause to roughly 50% or less of peak reproductive levels.
- Perimenopause = the 7–10 years before the final period, characterized by chaotic, unpredictable hormone fluctuations — called the “zone of chaos.”
- FSH surges increase as ovarian response diminishes; estradiol swings become dramatically amplified before eventually flatlining.
- No reliable blood test exists for perimenopause — diagnosis is primarily clinical and symptom-based.
Symptoms of Perimenopause
- Menstrual changes: irregular, heavier, or absent periods (affects ~90%)
- Mental health: increased anxiety, new-onset ADD-like symptoms, brain fog, loss of executive function, depression, reduced resilience
- Vasomotor symptoms: hot flashes, night sweats, palpitations
- Sleep disruption: difficulty falling or staying asleep
- Musculoskeletal: joint pain, hip pain, back pain with no identifiable structural cause
- Other: fatigue, vertigo, tinnitus, dry/itchy skin, crawling skin sensation, gut changes/bloating, loss of confidence
- SSRI prescription rates double across the menopause transition; hormone therapy may outperform SSRIs for menopause-related depression
Body Composition Changes
- Visceral fat (fat surrounding internal organs) rises from ~8% to ~23% of total fat through the menopause transition — even without dietary or exercise changes.
- Sarcopenia (muscle loss) accelerates, lowering basal metabolic rate and increasing insulin resistance.
- Waist-to-hip ratio is a practical proxy for visceral fat risk:
- < 0.7 = lower metabolic risk
- > 1.0 = likely elevated visceral fat
- Measure waist at narrowest point (or navel if no natural waist), hips at widest point, relaxed, first thing in morning
- Body composition (not just weight) is the meaningful metric — weight on the scale may not change even as muscle is lost and fat is gained.
Nutrition Recommendations
- Protein: 80–120g/day minimum; higher-end data from WHI suggests 1.5–1.7g/kg lean body mass reduces frailty risk. Spread intake across meals — don’t stack it all at dinner.
- Fiber: Target 25–32g/day (most women get 10–12g). Benefits: feeds the gut microbiome, slows glucose absorption, supports transit.
- Anti-inflammatory dietary patterns: Mediterranean diet and the Galveston Diet (an Americanized, anti-inflammatory, protein-forward version with optional intermittent fasting elements).
- Eat a variety of colors (phytochemicals); include fermented foods to support gut health.
- Minimize processed foods and high-sugar foods.
Exercise
- Resistance training 3–4 days/week is the priority — not cardio — for preserving muscle, bone, and metabolic health.
- Progressive overload is key; working with a personal trainer to build a safe program is recommended.
- Reducing or replacing excessive cardio (e.g., marathon training) with resistance training is more beneficial for long-term health in this life stage.
Gut Microbiome & Menopause
- The Zoe Nutrition Study (n=1,100) showed measurable gut microbiome changes through perimenopause — shifting from a typical female microbiome profile toward a male profile.
- Probiotic studies (Lactobacillus, Bifidobacterium) in menopausal women showed improvements in visceral fat and blood pressure.
- Diet-based support (yogurt, fermented foods, high-fiber foods) correlates with fewer menopausal symptoms in retrospective studies.
Hormone Replacement Therapy (HRT)
- Gold standard treatment for hot flashes and many other menopause symptoms.
- Restores estrogen signaling, recalibrates the hypothalamic thermostat, and supports neurotransmitter function (serotonin, dopamine, norepinephrine).
The WHI Study — What Went Wrong
- Average participant age: 63 (10–12 years post-menopause) — far past the critical treatment window.
- Excluded women with hot flashes to preserve blinding — removing the most symptomatic population.
- The increased breast cancer risk was relative, not absolute: from 4/1,000 to 5/1,000 women/year (a 1-in-1,000 absolute increase).
- The estrogen-only arm (women without uteruses) showed a 30% decreased risk of breast cancer.
- Results were announced at a press conference before peer review — leading to mass media alarm.
What the Data Actually Shows
- Starting HRT ages 50–59: ~50% reduced risk of cardiovascular disease and all-cause mortality (American Heart Association, 2020 analysis).
- The “timing hypothesis”: estrogen is protective when started near menopause onset; less effective (possibly harmful for stroke risk) when started after atherosclerosis has developed.
- Longer lifetime estrogen exposure (natural cycles + HRT) correlates with higher cognitive scores and healthier brain aging.
- Women